Abstract:The successful clinical application of immune checkpoint blockade (ICB) and chimeric antigen receptor T cells (CAR-T) therapeutics has attracted extensive attention to immunotherapy, however, their drawbacks such as limited specificity, persistence and toxicity haven't met the high expectations on efficient cancer treatments. Therapeutic cancer vaccines which instruct the immune system to capture tumor specific antigens, generate long-term immune memory and specifically eliminate cancer cells gradually become the most promising strategies to eradicate tumor. However, the disadvantages of some existing vaccines such as weak immunogenicity and in vivo instability have restricted their development. Nanotechnology has been recently incorporated into vaccine fabrication and exhibited promising results for cancer immunotherapy. Nanoparticles promote the stability of vaccines, as well as enhance antigen recognition and presentation owing to their nanometer size which promotes internalization of antigens by phagocytic cells. The surface modification with targeting units further permits the delivery of vaccines to specific cells. Meanwhile, nanocarriers with adjuvant effect can improve the efficacy of vaccines. In addition to classic vaccines composed of antigens and adjuvants, the nanoparticle-mediated chemotherapy, radiotherapy and certain other therapeutics could induce the release of tumor antigens in situ, which therefore effectively simulate antitumor immune responses. Such vaccine-like nanomedicine not only kills primary tumors, but also prevents tumor recurrence and helps eliminate metastatic tumors. Herein, we introduce recent developments in nanoparticle-based delivery systems for antigen delivery and in situ antitumor vaccination. We will also discuss the remaining opportunities and challenges of nanovaccine in clinical translation towards cancer treatment.

Advanced Nanovaccines Based on Engineering Nanomaterials for Accurately Enhanced Cancer Immunotherapy

Advances in Cancer Nanovaccines: Harnessing Nanotechnology for Broadening Cancer Immune Response

Tumor Antigen-Based Nanovaccines for Cancer Immunotherapy: A Review

Nanovaccines for Cancer Immunotherapy: Current Knowledge and Future Perspectives

Research progress of nanovaccine in anti-tumor immunotherapy

Nanobiomaterial-based vaccination immunotherapy of cancer

Nanovaccines: An effective therapeutic approach for cancer therapy

Cancer Vaccines Designed Based the Nanoparticle and Tumor Cells for the Treatment of Tumors: A Perspective

Vaccine-like Nanomedicine for Cancer Immunotherapy.

Engineering customized nanovaccines for enhanced cancer immunotherapy

Nanotechnology-based Multifunctional Vaccines for Cancer Immunotherapy

Improving Cancer Vaccine Efficiency by Nanomedicine

Nanoparticle Cancer Vaccines: Design Considerations and Recent Advances

Therapeutic Vaccines for Cancer Immunotherapy

Lymph Node-Targeting Nanovaccines for Cancer Immunotherapy

Nanotechnology-Assisted Immunoengineering for Cancer Vaccines

Anti-tumor Immune Potentiation Targets-Engineered Nanobiotechnologies: Design Principles and Applications

Nanotechnology-Based Approaches to Promote Lymph Node Targeted Delivery of Cancer Vaccines

Recent progress in cancer vaccines and nanovaccines

Targeted Nanoparticle Drug Delivery System for the Enhancement of Cancer Immunotherapy.

Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy